PD-1 in cancer cells inhibited NSCLC (H1299) tumor growth, whereas interference with PD-1 transcriptional activation significantly attenuated the p53-dependent tumor suppression, confirming the materiality of the p53-PD-1 axis. This evidence concerns the gene TP53 and cancer.